Skip to main content
Topic: Metabolomics and clinical practice (Read 952 times) previous topic - next topic

Re: Metabolomics and clinical practice

Reply #1
As a new Biomarker, yet to materialise. However, there are many new proposed ones. But it needs to pass the test of time and reproducibility. I would be also interested if anyone else came across one with good potentials. 

Re: Metabolomics and clinical practice

Reply #2
the problem is 'clinical routine'. It is really difficult to get legal approvals (e.g. in the United States, FDA), and to convince insurance companies to cover costs. Easily a decade, even if everything is perfect. Multiple studies on various cohorts of patients are needed before a clinical organization would consider discussing the topic, after meta-analysis (comparison) of those study outcomes.